Literature DB >> 21391930

Use of microvascular flap technique in older adults with head and neck cancer: a persisting dilemma in reconstructive surgery?

Marco R Kesting1, Frank Hölzle, Klaus-D Wolff, Stefan Wagenpfeil, Rafael J Hasler, Craig J Wales, Lars Steinstraesser, Nils H Rohleder.   

Abstract

OBJECTIVES: To compare perioperative problems and outcomes of reconstructive surgery with microvascular flaps of a group of older (≥ 70) and younger adults (20-69).
DESIGN: Prospective clinical cohort study.
SETTING: Maxillofacial surgical unit of a university teaching hospital in Munich, Germany. PARTICIPANTS: Two hundred fifteen people with head and neck carcinoma (older: n = 54, mean age 75.8, range 70-96; younger: n = 161, mean age 55.5, range 20-69) who underwent surgery between 2007 and 2009. MEASUREMENTS: Participant characteristics: age, sex, American Society of Anesthesiologists (ASA) status, tumor type, preoperative radiation or chemotherapy, medical comorbidities. Surgical variables: flap type, type of reconstruction (primary/secondary), length of operation (minutes). Postoperative variables: length of stay (minutes) on intensive care unit (ICU), reasons for ICU stay longer than 1,500 minutes (surgical or medical), length of hospitalization (days), and reasons for hospitalization longer than 20 days (surgical or /medical). Short-term outcome within 30 days: revisions, flap success, overall complication rate, mortality.
RESULTS: Older adults had a higher ASA class (P < .001) and shorter duration of surgery (P = .02). Age as an independent factor prolonged stay on ICU (P = .008) and was associated with a higher complication rate (P = .003) but had no influence on length of hospitalization, flap success, need for revisions, or mortality.
CONCLUSION: Although higher rates of peri- and postoperative difficulties must be expected when microvascular reconstructive surgery is considered for older adults, careful surgical technique, adequate postoperative surveillance, and immediate management of complications can facilitate outcomes comparable with those for younger adults.
© 2011, Copyright the Authors. Journal compilation © 2011, The American Geriatrics Society.

Entities:  

Mesh:

Year:  2011        PMID: 21391930     DOI: 10.1111/j.1532-5415.2011.03315.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  5 in total

1.  Analysis of outcome for elderly patients after microvascular flap surgery: a monocentric retrospective cohort study.

Authors:  Henning Hanken; Evgeny Barsukov; Friedemann Göhler; Susanne Sehner; Ralf Smeets; Benedicta Beck-Broichsitter; Max Heiland; Kilian Kreutzer; Alexander Gröbe
Journal:  Clin Oral Investig       Date:  2019-05-08       Impact factor: 3.573

2.  Incidence and risk factors for morbidity and mortality in elderly head and neck cancer patients undergoing major oncological surgery.

Authors:  Shin Hyuk Yoo; Jong-Lyel Roh; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-16       Impact factor: 4.553

3.  Effects of endothelial defects and venous interposition grafts on the acute incidence of thrombus formation within microvascular procedures.

Authors:  Andreas M Fichter; Thomas Mücke; Lucas M Ritschl; Marie-Kristin Hofmann; Constantin T Wolff; Leonard H Schmidt; Klaus-Dietrich Wolff
Journal:  Sci Rep       Date:  2021-04-22       Impact factor: 4.379

4.  A decade of reconstructive surgery: outcome and perspectives of free tissue transfer in the head and neck. Experience of a single center institution.

Authors:  Steffen Spoerl; Shlomo Schoedel; Gerrit Spanier; Karolina Mueller; Johannes K Meier; Torsten E Reichert; Tobias Ettl
Journal:  Oral Maxillofac Surg       Date:  2020-03-20

5.  A comparative analysis using flowmeter, laser-Doppler |spectrophotometry, and indocyanine green-videoangiography for detection of vascular stenosis in free flaps.

Authors:  Thomas Mücke; Alexander Hapfelmeier; Leonard H Schmidt; Andreas M Fichter; Anastasios Kanatas; Klaus-Dietrich Wolff; Lucas M Ritschl
Journal:  Sci Rep       Date:  2020-01-22       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.